← boothcheck

BDX vs DXCM stock comparison

BECTON, DICKINSON AND COMPANY vs DEXCOM, INC., two Medical Devices stocks. A side-by-side on valuation, growth, margins, returns, and what each price is betting.

Where BDX and DXCM diverge most: on return on equity, BDX reads 3.9% and DXCM reads 38.1%; on return on assets, BDX reads 1.9% and DXCM reads 15.5%. The rest of the comparable metrics sit closer together. On valuation, today's BDX price has a different growth bar priced in than DXCM (+9.0% implied for BDX vs +31.6% for DXCM); the higher figure is the steeper assumption to clear, not a better or worse stock. What BDX's price implies is a bet that sits within the historical range (whole-company basis). The bull and bear cases for each are in their full reports below.

BDX vs DXCM: the numbers

MetricBDXDXCM
Price$183.72$84.09
Market cap$50.6B$31.7B
SectorMedical DevicesMedical Devices
StageMatureGrowth
Implied growth (priced in)+9.0%+31.6%
P/E55.533.4
P/B2.0712.11
P/S2.436.39
EV/EBITDA16.122.7
Revenue growth+5.2%+15.7%
Gross margin—63.4%
Operating margin13.3%24.3%
Net margin4.5%20.1%
Return on equity3.9%38.1%
Return on assets1.9%15.5%
Return on invested capital4.0%23.1%
FCF yield7.6%4.4%
Dividend yield2.3%—
Debt / equity0.690.47
Current ratio0.871.73
Altman Z (solvency)6.916.85
Piotroski F (quality)8 / 98 / 9
Full BDX report → Full DXCM report →
Get boothcheck's read on BDX and DXCM, and what their prices are betting on, in your inbox. No hype, no spam.
Free. Informational only, not investment advice. Unsubscribe anytime.

Compare any two stocks

vs

The stronger value is highlighted per metric where one is strictly better on that single number; it is not an overall verdict on either company. For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.